文献速递血脂与心血管预防冠心病

载脂蛋白B脂蛋白的血浆蛋白质组学揭示动脉粥样硬化中的不同作用

Apolipoprotein B-containing lipoproteins: distinct roles in atherosclerosis revealed by plasma proteomic profiling.
PubMed 文献 · Eur Heart J · 2026-08-31

本研究基于英国生物银行(n=35,269)前瞻性队列,利用2918种血浆蛋白的多变量回归和孟德尔随机化,识别LDL、TRL和Lp(a)的特异性蛋白质组特征,并在多种族动脉粥样硬化研究(n=5915)中重复。结果显示TRL和Lp(a)特征与LDL不同但彼此重叠,且TRL和Lp(a)的多蛋白评分与 incident CAD 相关,而LDL评分不相关;炎症和血管重塑通路可能介导TRL和Lp(a)的促动脉粥样硬化作用。

要点

  • TRL和Lp(a)的蛋白质组特征与LDL不同,但两者高度重叠并富集炎症通路。
  • TRL多蛋白评分与 incident CAD 相关(HR 1.16),Lp(a)评分也相关(HR 1.09),LDL评分不相关。
  • 免疫激活和血管重塑标志物可能介导TRL相关CAD风险(62%)和部分Lp(a)风险(14%)。

核心结论

  • TRL和Lp(a)通过炎症和血管重塑通路汇聚,可能解释其相对于LDL更高的每颗粒致动脉粥样硬化性。

研究设计与样本

  • 基于英国生物银行的前瞻性队列(n=35,269)识别与LDL、TRL和Lp(a)相关的血浆蛋白,并用单样本孟德尔随机化验证。
  • 将一致鉴定的蛋白质汇总为脂蛋白特异性多蛋白评分,用Cox回归关联 incident CAD(n=1599事件),并进行高维中介分析。
  • 结果在多种族动脉粥样硬化研究(n=5915)中重复。

主要发现

  • 要求观察性与孟德尔随机化分析一致(均Bonferroni校正P<0.05),鉴定出30种蛋白与LDL相关、471种与TRL相关、53种与Lp(a)相关。
  • TRL和Lp(a)特征与LDL特征不同,但彼此重叠36种蛋白,共同富集于炎症通路。
  • 调整潜在混杂因素和测定的脂蛋白浓度后,TRL多蛋白评分与 incident CAD 相关(HR per 1-SD 1.16; 95%CI 1.08-1.24),Lp(a)评分相关(HR 1.09; 95%CI 1.03-1.15),LDL评分不相关(HR 0.95; 95%CI 0.89-1.02)。
  • 中介分析提示免疫激活和血管重塑标志物介导TRL相关CAD风险的比例为62%,部分介导Lp(a)相关风险为14%。

临床怎么用

  • 在临床风险评估中,除LDL外,应关注TRL和Lp(a)相关的炎症和血管重塑生物标志物。
  • 针对TRL和Lp(a)的干预可能通过抗炎或改善血管重塑途径降低CAD风险。

局限性

  • 中介分析基于观察性假设,不能确立因果关系。
  • 研究主要基于欧洲 ancestry 人群,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: All apolipoprotein B-containing lipoproteins are established causal factors for coronary artery disease (CAD). This study aimed to identify robust proteomic signatures of low-density lipoprotein (LDL), triglyceride-rich lipoproteins (TRL), and lipoprotein(a) [Lp(a)] and to evaluate whether these signatures illuminate biological processes underlying differences in per-particle atherogenicity. METHODS: Plasma proteins associated with LDL, TRL, and Lp(a) concentrations were identified using multivariable-adjusted regression across 2918 proteins in a primary prevention cohort based on UK Biobank (n=35,269), and findings were corroborated using one-sample Mendelian randomization. Proteins consistently identified by both approaches were summarized into lipoprotein-specific multi-protein scores and associated with incident CAD (n=1599 events) using Cox regression. High-dimensional mediation analysis quantified the proportion of lipoprotein-associated CAD risk explained by proteomic alterations. Findings were replicated in the Multi-Ethnic Study of Atherosclerosis (n=5915). RESULTS: Requiring concordance between observational and Mendelian randomization analyses (both Bonferroni-adjusted P<0.05), 30 proteins were identified as associated with LDL, 471 with TRL, and 53 with Lp(a). The TRL and Lp(a) signatures were distinct from the LDL signature yet overlapped substantially with each other (36 shared proteins), with common enrichment in inflammatory pathways. After adjustment for potential confounders and measured lipoprotein concentrations, the multi-protein scores for TRL (hazard ratio per 1-SD [HRSD], 1.16; 95% confidence interval [95%CI]: 1.08-1.24) and Lp(a) (HRSD, 1.09; 95%CI: 1.03-1.15), but not LDL (HRSD, 0.95; 95%CI: 0.89-1.02), were associated with incident CAD. Mediation analysis was consistent with immune activation and vascular remodeling markers mediating TRL-associated CAD risk (proportion mediated, 62%) and, in part, Lp(a)-associated risk (14%). CONCLUSIONS: Beyond arterial lipid deposition, TRL and Lp(a) converge on inflammatory and vascular remodeling pathways that, under the assumptions of observational mediation analysis, may explain their excess per-particle atherogenicity compared with LDL.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Morze J, Björnson E, Mi MY, et al. Apolipoprotein B-containing lipoproteins: distinct roles in atherosclerosis revealed by plasma proteomic profiling. Eur Heart J. 2026. PMID: 42671122. doi:10.1093/eurheartj/ehag718

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。